A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
Ertugliflozin
Cannabidiol may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Potassium cation
Talazoparib
Cannabidiol may decrease the excretion rate of Talazoparib which could result in a higher serum level.
Potassium cation
Velpatasvir
Cannabidiol may decrease the excretion rate of Velpatasvir which could result in a higher serum level.
Potassium cation
Venetoclax
Cannabidiol may decrease the excretion rate of Venetoclax which could result in a higher serum level.
Potassium cation
Osimertinib
Cannabidiol may decrease the excretion rate of Osimertinib which could result in a higher serum level.
Potassium cation
Tenofovir alafenamide
Cannabidiol may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level.
Potassium cation
Ombitasvir
Cannabidiol may decrease the excretion rate of Ombitasvir which could result in a higher serum level.
Potassium cation
Fimasartan
Cannabidiol may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Potassium cation
Lenvatinib
Cannabidiol may decrease the excretion rate of Lenvatinib which could result in a higher serum level.
Potassium cation
Palbociclib
Cannabidiol may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Potassium cation
Pitolisant
The serum concentration of Cannabidiol can be decreased when it is combined with Pitolisant.
Potassium cation
PCS-499
Cannabidiol may increase the excretion rate of PCS-499 which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
8-chlorotheophylline
Cannabidiol may increase the excretion rate of 8-chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Furafylline
Cannabidiol may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Bromotheophylline
Cannabidiol may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Bufylline
Cannabidiol may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Pentifylline
Cannabidiol may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Etamiphylline
Cannabidiol may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Acefylline
Cannabidiol may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Proxyphylline
Cannabidiol may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3